NCI-DCP-21-0103 coordinating center for the NCI cervical cancer last mile initiative self-sampling for HPV testing to improve cervical cancer prevention ship trial
Active Awarded Last action
- Contract number
- 75N91021F00014
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,985,184
Award facts
- Contract value 100% obligated
- $7,985,184.00 Current and potential, with all options
- Completion date 96% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21703, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,888,290 | |
| Original award | $6,096,894 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 14, 2021, with a ceiling value of $7.985 million for coordinating center services supporting the NCI Cervical Cancer Last Mile Initiative Self-Sampling for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial.
Place of performance is Frederick, MD. The order is cost-plus-fixed-fee with an ultimate completion date of December 31, 2026. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor subsidiary of Leidos Holdings, Inc.
Service Contract Inventory data reflects actual government-invoiced labor. FY2024 labor footprint was 5.6 FTEs across 11,736 contractor hours, with one subcontractor representing 5 percent of subcontracted hours. Invoiced amounts grew from $317 thousand in FY2021 to $658 thousand in FY2024. Derived government-paid hourly rates declined from $86.94/hr in FY2022 to $56.10/hr in FY2024.
Quick answers
Who was awarded contract 75N91021F00014?
75N91021F00014 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 14, 2021.
How much is contract 75N91021F00014 worth?
The government has obligated $7,985,184 on 75N91021F00014.
Is contract 75N91021F00014 an order under another contract?
Yes. 75N91021F00014 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00014 competed?
The extent of competition for 75N91021F00014 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award